Sclerosing Mesenteritis: A Concise Clinical Review for Clinicians

B Saha, J Tome, XJ Wang - Mayo Clinic Proceedings, 2024 - Elsevier
Sclerosing mesenteritis (SM), an idiopathic nonneoplastic condition affecting 0.18% to
3.14% of the population, is characterized by chronic fat necrosis, inflammation, and fibrosis …
被引用次数：1 相关文章

Sclerosing Mesenteritis: A Concise Clinical Review for Clinicians.

B Saha, J Tome, XJ Wang - Mayo Clinic Proceedings, 2024 - europepmc.org
Sclerosing mesenteritis (SM), an idiopathic nonneoplastic condition affecting 0.18% to
3.14% of the population, is characterized by chronic fat necrosis, inflammation, and fibrosis …

Sclerosing Mesenteritis: A Concise Clinical Review for Clinicians

B Saha, J Tome, XJ Wang - Mayo Clinic Proceedings, 2024 - mayoclinicproceedings.org
Sclerosing mesenteritis (SM), an idiopathic nonneoplastic condition affecting 0.18% to
3.14% of the population, is characterized by chronic fat necrosis, inflammation, and fibrosis …

Sclerosing Mesenteritis: A Concise Clinical Review for Clinicians

B Saha, J Tome, XJ Wang - Mayo Clinic proceedings, 2024 - pubmed.ncbi.nlm.nih.gov
Sclerosing mesenteritis (SM), an idiopathic nonneoplastic condition affecting 0.18% to
3.14% of the population, is characterized by chronic fat necrosis, inflammation, and fibrosis …